Acceptability of the reusable SurePal™ self-injection device for Omnitrope® among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter obs...

por Partsch CJ, Schnabel D, Ehtisham S, Johnstone HC, Zabransky M, Kiess W
Publicado 2015

Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observation...

por Schnabel D, Partsch CJ, Houang M, Ehtisham S, Johnstone H, Zabransky M, Kiess W
Publicado 2016

Validation and ease of use of a new pen device for self-administration of recombinant human growth hormone: results from a two-center usability study

por Rapaport R, Saenger P, Schmidt H, Hasegawa Y, Colle M, Loche S, Marcantonio S, Bonfig W, Zabransky M, Lifshitz F
Publicado 2013